Drug Type Small molecule drug |
Synonyms OBP 2011, OBP-2011 |
Target- |
Action inhibitors |
Mechanism Virus replication inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Virus Diseases | Preclinical | Japan | 01 Aug 2026 | |
| COVID-19 | Preclinical | Japan | 19 Jun 2020 |





